High Tide Up 9% In US Premarket As Says to Become "Major Player" in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian-March 2024-www.financetom.com

High Tide Up 9% In US Premarket As Says to Become "Major Player" in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

High Tide Up 9% In US Premarket As Says to Become "Major Player" in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian

Aug 14, 2025 5:37 AM

08:16 AM EDT, 08/14/2025 (MT Newswires) -- Cannabis retailer High Tide (Nasdaq and TSXV: HITI) was up 9% in US premarket trade on Thursday after announcing that it is entering the "fast growing" German medical cannabis market by signing a definitive agreement that will see it acquire 51% of Remexian Pharma GmbH, for a preliminary estimated purchase price of 27.2 million euros

A statement noted the purchase price is subject to certain adjustments on closing, and High Tide will have an option to acquire the remaining interest in Remexian.

Thursday's statement also noted Remexian generated 65 million euros in revenue in the last 12 months and it sold seven tonnes of cannabis flower in Q2 2025, representing 16% of the 43 tonnes imported into Germany in that quarter.

Previous page： Tesla picks showroom sites in New Delhi, Mumbai to start India sales, sources say Next page： Espey Mfg. & Electronics Names Kaitlyn O'Neil as Principal Financial Officer

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Tesla picks showroom sites in New Delhi, Mumbai to start India sales, sources say

Feb 18, 2025

By Aditya Kalra NEW DELHI (Reuters) - Tesla has selected locations for two showrooms in the Indian cities of New Delhi and Mumbai, moving closer to its long-delayed plans to sell its electric cars in the country, sources familiar with the matter said. The U.S. carmaker has been hunting for showroom space in India since late last year in order...

Espey Mfg. & Electronics Names Kaitlyn O'Neil as Principal Financial Officer

Feb 18, 2025

08:44 AM EST, 02/18/2025 (MT Newswires) -- Espey Mfg. & Electronics Corp. ( ESP ) said Tuesday it has named Kaitlyn O'Neil as principal financial officer and treasurer, effective Feb. 15. The appointment comes after the retirement of Katrina Sparano, who served as chief financial officer of the company. ...

Purple Biotech Moves NT219 Into Phase 2 Trial Aimed at Overcoming Tumor Resistance in Head, Neck Cancer Therapies

Feb 18, 2025

08:41 AM EST, 02/18/2025 (MT Newswires) -- Purple Biotech ( PPBT ) said Tuesday it is advancing its drug candidate NT219 into a phase 2 clinical trial aimed at overcoming tumor resistance in therapies for recurring metastatic squamous cell cancer of the head and neck. The study will evaluate the safety and efficacy of NT219 in combination with standard therapies...

Ultragenyx Pharmaceutical Eyes Aug. 18 FDA Approval for Sanfilippo Syndrome Gene Therapy Treatment

Feb 18, 2025

08:38 AM EST, 02/18/2025 (MT Newswires) -- Ultragenyx Pharmaceutical ( RARE ) said Tuesday that its UX111, ABO-102, AAV gene therapy, a treatment for patients with Sanfilippo syndrome type A, has been accepted for review by the U.S. Food and Drug Administration. In response to the company's request for accelerated approval, the U.S. health regulator has given a decision date...